Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

National Institutes of Health

Federal funding opportunity PAR-25-074 published by National Institutes of Health. Review the official synopsis for eligibility, award terms, and application requirements.